MPM BioImpact LLC - 31 Dec 2024 SCHEDULE 13G Report for Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX)

Filing Manager: MPM BioImpact LLC
Reporting Manager: MPM BioImpact LLC
Security: Context Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol: CNTX
Shares outstanding: 89,670,012 shares
Disclosed Ownership: 14,705,882 shares
Ownership: 16%
Form type: SCHEDULE 13G
Filing time: 08 Jan 2025, 16:07:08 UTC
Date of event: 31 Dec 2024
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
MPM BioImpact LLC	16%	14,705,882	14,705,882	0	Christopher Wolf	Chief Financial Officer